NASDAQ : VIVS
VivoSim Labs, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.1577 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.62M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
VivoSim Labs, Inc. (VIVS) reported revenue of 112.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 112.00K | 131.00K | 144.00K | 109.00K | 370.00K | 1.50M |
| Cost of Revenue | 4.32M | 4.19M | 5.03M | 5.50M | 8.88M | 3.32M |
| Gross Profit | -4.21M | -4.06M | -4.89M | -5.39M | -8.52M | -1.82M |
| Selling, General & Admin | 7.12M | 7.43M | 7.73M | 9.70M | 9.22M | 9.66M |
| Operating Expenses | 7.12M | 7.43M | 7.73M | 9.70M | 9.22M | 9.66M |
| Operating Income | -11.33M | -11.49M | -12.62M | -15.09M | -17.73M | -11.48M |
| Interest Expense | -12.00K | -12.00K | -10.00K | |||
| Interest & Investment Income | 219.00K | 267.00K | 140.00K | 405.00K | 454.00K | 8.00K |
| Other Non Operating Income (Expenses) | -1.30M | -2.70M | 25.00K | |||
| EBT Excluding Unusual Items | -12.43M | -13.94M | -12.49M | -14.68M | -17.28M | -11.45M |
| Gain (Loss) on Sale of Investments | 94.00K | 94.00K | 12.00K | 29.00K | ||
| Gain (Loss) on Sale of Assets | 10.00M | -9.00K | ||||
| Pretax Income | -12.33M | -13.84M | -2.49M | -14.67M | -17.26M | -11.45M |
| Income Tax Expense | 5.00K | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Net Income | -12.34M | -13.84M | -2.49M | -14.67M | -17.26M | -11.45M |
| Net Income to Common | -12.34M | -13.84M | -2.49M | -14.67M | -17.26M | -11.45M |
| Shares Outstanding (Basic) | 3.27M | 2.59M | 1.46M | 762.08K | 726.09K | 725.30K |
| Shares Outstanding (Diluted) | 3.27M | 2.59M | 1.46M | 762.08K | 726.09K | 725.30K |
| EPS (Basic) | -3.77 | -5.35 | -1.70 | -19.25 | -23.77 | -15.78 |
| EPS (Diluted) | -3.77 | -5.35 | -1.70 | -19.25 | -23.77 | -15.78 |
| Free Cash Flow | -10.12M | -10.83M | -9.47M | -14.70M | -12.80M | -8.86M |
| Free Cash Flow Per Share | -3.09 | -4.18 | -6.47 | -19.28 | -17.63 | -12.22 |
| Gross Margin | -121.33% | |||||
| Operating Margin | -10,116.96% | -8,768.70% | -8,761.11% | -13,840.37% | -4,792.16% | -765.27% |
| Profit Margin | -11,016.07% | -10,567.18% | -1,727.78% | -13,459.63% | -4,664.60% | -763.20% |
| Free Cash Flow Margin | -9,038.39% | -8,264.89% | -6,579.17% | -13,481.65% | -3,460.54% | -590.80% |
| EBITDA | -11.14M | -11.27M | -12.35M | -14.81M | -17.44M | -11.34M |
| D&A For EBITDA | 194.00K | 215.00K | 266.00K | 280.00K | 293.00K | 142.00K |
| EBIT | -11.33M | -11.49M | -12.62M | -15.09M | -17.73M | -11.48M |
| Revenue as Reported | 112.00K | 131.00K | 144.00K | 109.00K | 370.00K | 1.50M |
Balance sheet
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.67M | 5.02M | 11.31M | 2.90M | 15.30M | 28.68M |
| Short-Term Investments | 706.00K | |||||
| Cash & Short-Term Investments | 1.67M | 5.02M | 11.31M | 2.90M | 16.01M | 28.68M |
| Accounts Receivable | 29.00K | 32.00K | 30.00K | 33.00K | 152.00K | |
| Other Receivables | 1.01M | |||||
| Receivables | 29.00K | 1.05M | 30.00K | 33.00K | 152.00K | |
| Inventory | 297.00K | |||||
| Prepaid Expenses | 511.00K | 557.00K | 777.00K | 701.00K | 820.00K | 858.00K |
| Other Current Assets | 1.02M | 12.00K | 4.00K | 69.00K | ||
| Total Current Assets | 3.23M | 6.63M | 12.13M | 3.94M | 17.05M | 29.53M |
| Property, Plant & Equipment | 476.00K | 613.00K | 1.29M | 1.97M | 2.61M | 2.81M |
| Other Intangible Assets | 8.00K | 13.00K | 94.00K | |||
| Other Long-Term Assets | 145.00K | 146.00K | 1.23M | 437.00K | 645.00K | 854.00K |
| Total Assets | 3.85M | 7.39M | 14.65M | 6.35M | 20.31M | 33.30M |
| Accounts Payable | 621.00K | 1.02M | 1.64M | 627.00K | 331.00K | 415.00K |
| Accrued Expenses | 738.00K | 981.00K | 1.23M | 727.00K | 2.85M | 489.00K |
| Short-Term Debt | 118.00K | 128.00K | ||||
| Current Portion of Leases | 316.00K | 447.00K | 521.00K | 506.00K | 492.00K | 479.00K |
| Other Current Liabilities | 218.00K | 218.00K | 218.00K | |||
| Total Current Liabilities | 1.89M | 2.79M | 3.74M | 1.86M | 3.67M | 1.38M |
| Long-Term Leases | 421.00K | 888.00K | 1.31M | 1.70M | ||
| Other Long-Term Liabilities | 4.30M | 5.70M | ||||
| Total Liabilities | 6.19M | 8.48M | 4.16M | 2.75M | 4.98M | 3.09M |
| Common Stock | 3.00K | 3.00K | 2.00K | 1.00K | 9.00K | 9.00K |
| Additional Paid-In Capital | 354.99M | 354.90M | 352.65M | 343.27M | 340.32M | 337.94M |
| Retained Earnings | -357.34M | -356.00M | -342.16M | -339.67M | -325.00M | -307.74M |
| Treasury Stock | -1.00K | -1.00K | -1.00K | -1.00K | ||
| Comprehensive Income & Other | 2.00K | |||||
| Shareholders' Equity | -2.35M | -1.10M | 10.49M | 3.60M | 15.33M | 30.21M |
| Total Liabilities & Equity | 3.85M | 7.39M | 14.65M | 6.35M | 20.31M | 33.30M |
| Total Debt | 316.00K | 565.00K | 1.07M | 1.39M | 1.80M | 2.18M |
| Net Cash (Debt) | 1.35M | 4.46M | 10.24M | 1.51M | 14.20M | 26.49M |
| Net Cash Per Share | 0.41 | 1.72 | 7.00 | 1.98 | 19.56 | 36.53 |
| Filing Date Shares Outstanding | 14.85M | 3.49M | 2.60M | 1.20M | 726.41K | 725.89K |
| Total Common Shares Outstanding | 3.19M | 2.89M | 1.90M | 839.81K | 726.40K | 725.88K |
| Working Capital | 1.33M | 3.84M | 8.39M | 2.08M | 13.38M | 28.15M |
| Book Value Per Share | -0.73 | -0.38 | 5.53 | 4.29 | 21.10 | 41.62 |
| Tangible Book Value | -2.35M | -1.10M | 10.49M | 3.59M | 15.32M | 30.11M |
| Tangible Book Value Per Share | -0.73 | -0.38 | 5.53 | 4.28 | 21.08 | 41.49 |
| Machinery | 1.70M | 1.70M | 1.68M | 1.64M | 1.21M |
Cash flow statement
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -12.34M | -13.84M | -2.49M | -14.67M | -17.26M | -11.45M |
| Depreciation & Amortization | 194.00K | 215.00K | 266.00K | 280.00K | 293.00K | 142.00K |
| Loss (Gain) From Sale of Assets | -10.00M | 9.00K | ||||
| Loss (Gain) From Sale of Investments | -94.00K | -94.00K | -38.00K | -154.00K | -134.00K | |
| Stock-Based Compensation | 316.00K | 303.00K | 532.00K | 1.51M | 2.38M | 2.26M |
| Other Operating Activities | 1.90M | 3.29M | 1.23M | 406.00K | ||
| Change in Accounts Receivable | 3.00K | -2.00K | 3.00K | 119.00K | -152.00K | |
| Change in Inventory | -501.00K | -297.00K | ||||
| Change in Accounts Payable | -52.00K | -623.00K | 1.02M | 296.00K | -148.00K | 134.00K |
| Change in Other Net Operating Assets | -26.00K | -70.00K | 518.00K | -2.14M | 2.61M | 463.00K |
| Operating Cash Flow | -10.10M | -10.83M | -9.46M | -14.65M | -12.41M | -8.45M |
| Capital Expenditures | -23.00K | -13.00K | -42.00K | -396.00K | -409.00K | |
| Sale of Property, Plant & Equipment | 9.00M | |||||
| Investment in Securities | 94.00K | 94.00K | 38.00K | 858.00K | -570.00K | |
| Investing Cash Flow | 71.00K | 94.00K | 9.03M | 816.00K | -966.00K | -409.00K |
| Short-Term Debt Repaid | -363.00K | |||||
| Total Debt Repaid | -353.00K | -363.00K | ||||
| Net Debt Issued (Repaid) | -353.00K | -363.00K | ||||
| Issuance of Common Stock | 3.00M | 4.81M | 8.85M | 1.44M | 251.00K | |
| Repurchase of Common Stock | -46.00K | |||||
| Financing Cash Flow | 2.64M | 4.45M | 8.85M | 1.44M | 205.00K | |
| Net Cash Flow | -7.38M | -6.29M | 8.41M | -12.40M | -13.37M | -8.66M |
| Free Cash Flow | -10.12M | -10.83M | -9.47M | -14.70M | -12.80M | -8.86M |
| Free Cash Flow Margin | -9,038.39% | -8,264.89% | -6,579.17% | -13,481.65% | -3,460.54% | -590.80% |
| Free Cash Flow Per Share | -3.09 | -4.18 | -6.47 | -19.28 | -17.63 | -12.22 |
| Levered Free Cash Flow | -7.58M | -8.32M | -5.16M | -9.50M | -6.72M | -4.83M |
| Unlevered Free Cash Flow | -7.57M | -8.31M | -5.15M | -9.50M | -6.72M | -4.83M |
| Cash Interest Paid | 12.00K | 12.00K | 10.00K | |||
| Cash Income Tax Paid | 5.00K | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Change in Working Capital | -75.00K | -695.00K | 1.04M | -2.02M | 2.31M | 597.00K |
Ratios
Fiscal year April - March; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.56M | 3.73M | 3.99M | 10.34M | 19.08M | 32.73M |
| Enterprise Value | 1.21M | 253.38K | 4.15M | 6.55M | 236.86K | 4.73M |
| Last Close Price | 0.15 | 1.43 | 2.24 | 12.36 | 26.28 | 45.12 |
| PS Ratio | 22.90 | 28.47 | 27.74 | 94.87 | 51.58 | 21.82 |
| PB Ratio | -3.39 | 0.38 | 2.87 | 1.25 | 1.08 | |
| P/TBV Ratio | 0.38 | 2.88 | 1.25 | 1.09 | ||
| EV/Sales Ratio | 10.81 | 1.93 | 28.82 | 60.07 | 0.64 | 3.16 |
| Debt / Equity Ratio | -0.14 | -0.51 | 0.10 | 0.39 | 0.12 | 0.07 |
| Net Debt / Equity Ratio | 0.58 | 4.06 | -0.98 | -0.42 | -0.93 | -0.88 |
| Net Debt / EBITDA Ratio | 0.12 | 0.40 | 0.83 | 0.10 | 0.81 | 2.34 |
| Net Debt / FCF Ratio | 0.13 | 0.41 | 1.08 | 0.10 | 1.11 | 2.99 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 |
| Quick Ratio | 0.90 | 2.18 | 3.04 | 1.58 | 4.40 | 20.73 |
| Current Ratio | 1.70 | 2.38 | 3.25 | 2.12 | 4.64 | 21.35 |
| Return on Equity (ROE) | -343.10% | -294.75% | -35.31% | -155.00% | -75.80% | -32.99% |
| Return on Assets (ROA) | -89.50% | -65.16% | -75.10% | -70.73% | -41.34% | -19.60% |
| Return on Capital Employed (ROCE) | -579.90% | -249.70% | -115.60% | -336.10% | -106.50% | -36.00% |
| Earnings Yield | -2,438.86% | -371.19% | -62.28% | -141.87% | -90.43% | -34.97% |
| FCF Yield | -394.77% | -290.32% | -237.17% | -142.10% | -67.09% | -27.07% |
| Buyback Yield / Dilution | -83.42% | -76.85% | -92.06% | -4.96% | -0.11% | -26.10% |